
Lotus Eye Hospital & Institute Ltd is Rated Sell
2026-05-19 10:10:22Lotus Eye Hospital & Institute Ltd is rated Sell by MarketsMOJO. This rating was last updated on 07 May 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 19 May 2026, providing investors with the latest insights into its performance and outlook.
Read MoreResults - Standalone Unaudited Financial Results For The Quarter Ended June 30 2026
10-Aug-2026 | Source : BSEStandalone Unaudited Financial Results for the quarter ended June 30 2026.
Board Meeting Outcome for Standalone Unaudited Financial Results For The Quarter Ended June 30 2026
10-Aug-2026 | Source : BSEApproved Standalone Unaudited Financial Results for the quarter ended June 30 2026.
Board Meeting Intimation for Board Meeting Intimation For Consideration And Approval Of The Unaudited Financial Results For The Quarter Ended June 30 2026
01-Aug-2026 | Source : BSELotus Eye Hospital And Institute Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 10/08/2026 inter alia to consider and approve Unaudited Financial Results For The Quarter Ended June 30 2026
Corporate Actions
No Upcoming Board Meetings
Lotus Eye Hospital & Institute Ltd has declared 5% dividend, ex-date: 18 Sep 23
No Splits history available
No Bonus history available
No Rights history available